chr17-7885025-C-CCCG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001005271.3(CHD3):c.240_242dupGCC(p.Pro81dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00874 in 1,161,150 control chromosomes in the GnomAD database, including 49 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 17 hom., cov: 27)
Exomes 𝑓: 0.0082 ( 32 hom. )
Consequence
CHD3
NM_001005271.3 disruptive_inframe_insertion
NM_001005271.3 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.312
Genes affected
CHD3 (HGNC:1918): (chromodomain helicase DNA binding protein 3) This gene encodes a member of the CHD family of proteins which are characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. This protein is one of the components of a histone deacetylase complex referred to as the Mi-2/NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Chromatin remodeling is essential for many processes including transcription. Autoantibodies against this protein are found in a subset of patients with dermatomyositis. Three alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
NAA38 (HGNC:28212): (N-alpha-acetyltransferase 38, NatC auxiliary subunit) Involved in negative regulation of apoptotic process. Located in cytoplasm and nucleoplasm. Part of NatC complex. Colocalizes with polysome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 17-7885025-C-CCCG is Benign according to our data. Variant chr17-7885025-C-CCCG is described in ClinVar as [Likely_benign]. Clinvar id is 1210084.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0125 (1789/143262) while in subpopulation AFR AF= 0.0157 (628/40050). AF 95% confidence interval is 0.0147. There are 17 homozygotes in gnomad4. There are 837 alleles in male gnomad4 subpopulation. Median coverage is 27. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1789 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD3 | NM_001005271.3 | c.240_242dupGCC | p.Pro81dup | disruptive_inframe_insertion | Exon 1 of 40 | NP_001005271.2 | ||
CHD3 | XM_005256427.5 | c.240_242dupGCC | p.Pro81dup | disruptive_inframe_insertion | Exon 1 of 40 | XP_005256484.1 | ||
CHD3 | XM_006721423.4 | c.240_242dupGCC | p.Pro81dup | disruptive_inframe_insertion | Exon 1 of 40 | XP_006721486.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD3 | ENST00000700753.1 | c.240_242dupGCC | p.Pro81dup | disruptive_inframe_insertion | Exon 1 of 40 | ENSP00000515165.1 | ||||
CHD3 | ENST00000380358.9 | c.240_242dupGCC | p.Pro81dup | disruptive_inframe_insertion | Exon 1 of 40 | 2 | ENSP00000369716.4 | |||
NAA38 | ENST00000576861.5 | c.-167+137_-167+139dupCGG | intron_variant | Intron 1 of 4 | 3 | ENSP00000461545.1 | ||||
NAA38 | ENST00000570555.1 | n.74+137_74+139dupCGG | intron_variant | Intron 1 of 4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1784AN: 143162Hom.: 17 Cov.: 27
GnomAD3 genomes
AF:
AC:
1784
AN:
143162
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00241 AC: 8AN: 3314Hom.: 0 AF XY: 0.00166 AC XY: 3AN XY: 1804
GnomAD3 exomes
AF:
AC:
8
AN:
3314
Hom.:
AF XY:
AC XY:
3
AN XY:
1804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00821 AC: 8354AN: 1017888Hom.: 32 Cov.: 30 AF XY: 0.00813 AC XY: 3928AN XY: 482952
GnomAD4 exome
AF:
AC:
8354
AN:
1017888
Hom.:
Cov.:
30
AF XY:
AC XY:
3928
AN XY:
482952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0125 AC: 1789AN: 143262Hom.: 17 Cov.: 27 AF XY: 0.0120 AC XY: 837AN XY: 69586
GnomAD4 genome
AF:
AC:
1789
AN:
143262
Hom.:
Cov.:
27
AF XY:
AC XY:
837
AN XY:
69586
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
CHD3: BS1, BS2 -
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at